Lv3
296 积分 2025-05-19 加入
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study
10小时前
待确认
BAricitinib in patients with SystemIC Sclerosis (BASICS): a prospective, open-label, randomised trial
1天前
已完结
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
1天前
已完结
Biomarkers of fibrosis, inflammation, and extracellular matrix in the phase 3 trial of tocilizumab in systemic sclerosis
1天前
已完结
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial
1天前
已完结
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
1天前
已完结
Efficacy and safety of low dose Mycophenolate mofetil treatment for immunoglobulin G4-related disease: a randomized clinical trial
1天前
已完结
Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial
1天前
已完结
A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease
1天前
已完结
Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: A randomized clinical trial
1天前
已完结
皖公网安备34019202002308
